Federal Register / Vol. 63, No. 75 / Monday, April 20, 1998 / Notices 19501

annually provide, ‘‘to the maximum

extent practical,’’ an annual data report.

Data elements include the number of

children reported for child abuse and

neglect; the number of children for

whom maltreatment was substantiated,

unsubstantiated or determined to be

false; the number of deaths resulting

from child abuse or neglect; the number

of children who received services;

agency response times; and the number

of workers responsible for child

protective service (CPS) functions. The

new annual State data report is being

combined with the previously existing

voluntary Summary Data Component of

the National Child Abuse and Neglect

Data System. The information collected

will be used to understand better the

experiences of children and families

served by CPS agencies, and to help

guide policy and program development

at the National, State and local levels.

Respondents: State, Local or Tribal

Govt.

ANNUAL BURDEN ESTIMATES

Instrument Number of respondents

Number of responses per

respondent

Average burden hours per

response

Total burden

hours

SDC .................................................................................................................. 56 1 60 3,360

Estimated Total Annual Burden Hours: 3,360.

Additional Information: Copies of the

proposed collection may be obtained by

writing to The Administration for

Children and Families, Office of

Information Services, 370 L’Enfant

Promenade, S.W., Washington, D.C.

20447, Attn: ACF Reports Clearance

Officer.

OMB Comment: OMB is required to

make a decision concerning the

collection of information between 30

and 60 days after publication of this

document in the Federal Register.

Therefore, a comment is best assured of

having its full effect if OMB receives it

within 30 days of publication. Written

comments and recommendations for the

proposed information collection should

be sent directly to the following: Office

of Management and Budget, Paperwork

Reduction Project, 725 17th Street,

N.W., Washington, D.C. 20503, Attn:

Ms. Laura Oliven.

Dated: April 13, 1998.

Bob Sargis,

Acting Reports Clearance Officer.

[FR Doc. 98–10256 Filed 4–17–98; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Antiviral Drugs Advisory Committee;

Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Antiviral Drugs

Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on FDA

regulatory issues.

Date and Time: The meeting will be

held on May 4, 1998, 8:30 a.m to 5 p.m.;

on May 5, 1998, 8 a.m. to 5 p.m.; and

on May 6, 1998, 7:30 a.m. to 5 p.m.

Location: Gaithersburg Hilton,

Ballroom, 620 Perry Pkwy.,

Gaithersburg, MD.

Contact Person: Rhonda W. Stover or

John B. Schupp, Center for Drug

Evaluation and Research (HFD–21),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–443–5455, or FDA Advisory

Committee Information Line, 1–800–

741–8138 (301–443–0572 in the

Washington, DC area), code 12531.

Please call the Information Line for upto-date information on this meeting.

Agenda: On May 4, 1998, the

committee will discuss new drug

application (NDA) 20–903, IntronA/

Rebetol, (interferon alfa-2b,

recombinant/ribavirin, Schering Corp.)

for the treatment of chronic hepatitis C.

On May 5, 1998, the committee will

discuss NDA 50–752, Priftin

(rifapentine, Hoechst Marion Roussel,

Inc.) for the treatment of pulmonary

tuberculosis. On May 6, 1998, the

committee will discuss NDA 20–871,

NTZTM (nitazoxanide, UNIMED

Pharmaceuticals, Inc.) for the treatment

of diarrhea associated with

cryptosporidiosis in acquired immune

deficiency syndrome (AIDS) patients.

Procedure: On May 4, 1998, from 8:30

a.m. to 5 p.m.; on May 5, 1998, from 8

a.m. to 10:30 a.m. and from 12 m. to 5

p.m.; and on May 6, 1998, from 9 a.m.

to 5 p.m., the meeting is open to the

public. Interested persons may present

data, information, or views, orally or in

writing, on issues pending before the

committee. Written submissions may be

made to the contact person by April 27,

1998. Oral presentations from the public

will be scheduled between

approximately 11 a.m. and 12 m. on

May 4 and May 6, 1998. On May 5,

1998, oral presentations from the public

will be scheduled between

approximately 1 p.m. and 2 p.m. Time

allotted for each presentation may be

limited. Those desiring to make formal

oral presentations should notify the

contact person before April 27, 1998,

and submit a brief statement of the

general nature of the evidence or

arguments they wish to present, the

names and addresses of proposed

participants, and an indication of the

approximate time requested to make

their presentation.

Closed Committee Deliberations: On

May 5, 1998, from 10:30 a.m. to 12 m.,

the meeting will be closed for a

presentation of confidential material (5

U.S.C. 552(b)(2) and (b)(5)). On May 6,

1998, from 7:30 a.m. to 9 a.m., the

meeting will be closed to permit

discussion and review of trade secret

and/or confidential information (5

U.S.C. 552(b)(4)). The selected NDA’s

will be discussed.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: April 14, 1998.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 98–10311 Filed 4–17–98; 8:45 am]

BILLING CODE 4160–01–F